Nantahala Capital Management »

ADC Therapeutics SA shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $231k 257k 0.90
2023-06-30 $1.8M 840k 2.15
2023-03-31 $1.6M 840k 1.95
2022-12-31 $934k 243k 3.84

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding ADC Therapeutics SA

Redmile Group
Millennium Management
Citadel Advisors
Bank of America Corporation
Goldman Sachs Group
Vantage Consulting Group
Blue Owl Capital Holdings
Jane Street
Indie Asset Partners
Miracle Mile Advisors
Hrt Financial
Hennion & Walsh Asset Management
DLK Investment Management
Marshall Wace
Saxony Capital Management

View all funds holding ADC Therapeutics SA